Johnson & Johnson's Fiscal Year is From January To December - All Figures are in USD, Billions.
The item "Retained-Earnings" stands at 167.28 Billion United States Dollars as of 09/30/2025, the highest value at least since 03/31/2011, the period currently displayed.
As of the end of Johnson & Johnson's third quarter, the item "Retained Earnings" stands at 167.28 Billion USD. This represents an increase of 1.15 percent compared to it's value at the end of it's second quarter .
Regarding the One-Year-Change of the series, the current value constitutes an increase of 7.80 percent compared to the value the year prior.
The 1 year change in percent is 7.80.
The 3 year change in percent is 30.77.
The 5 year change in percent is 45.68.
The 10 year change in percent is 62.81.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Retained Earnings | 905,699,262,464.00 |
![]() | AbbVie Inc - Retained Earnings | 399,570,305,024.00 |
![]() | Roche Holding AG - Retained Earnings | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Retained Earnings | 280,205,508,085.11 |
![]() | Novartis AG - Retained Earnings | 255,096,620,580.91 |